Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach

by Soldi S, Vasileiadis S, Uggeri F, Campanale M, Morelli L, Fogli MV, Calanni F, Grimaldi M, Gasbarrini A
Published 2015-12-01

Barrier Effect of a New Topical Agent on Damaged Esophageal Mucosa: Experimental Study on an ex vivo Swine Model

by Salaroli R, Ventrella D, Bernardini C, Elmi A, Zannoni A, Bacci ML, Forni M, Calanni F, Ferrieri A, Baldi F
Published 2020-11-01